UPDATE 1-Mylan still on the prowl for deals, perhaps one by end 2015

March 2 (Reuters) - U.S. generic drug maker Mylan Inc is still on the prowl for more deals, after completing the multibillion-dollar acquisition of some of Abbott Laboratories' non-U.S. businesses...

from Reuters: Mergers News http://ift.tt/1ARRk27